AI, mobile integration drive surge in smart inhaler adoptions

Rising need for personalised and remote healthcare also drives adoption.

The global smart inhalers market is set to reach $108.96b by 2034, according to a new report from Polaris Market Research.

Smart inhalers combine traditional drug delivery with sensors and wireless technology to monitor usage, track adherence, and provide real-time feedback to patients and healthcare providers.

The devices are increasingly used to manage asthma and chronic obstructive pulmonary disease (COPD), where correct inhalation and medication adherence are critical.

Market growth is being fueled by increasing patient demand for personalised, remote healthcare solutions, along with the integration of artificial intelligence and mobile applications into inhaler systems.

Collaborations between pharmaceutical companies and digital health tech providers are expanding, whilst regulatory support and reimbursement models for connected devices further boost adoption.

Advances in sensors, machine learning, and connectivity are expected to keep driving innovation, making smart inhalers a key tool in disease management and preventative care.